Navigation Links
IP-K extends research deal with Novartis Institute for Tropical Diseases
Date:12/2/2010

Dec. 03, 2010, Seoul, S. Korea Institut Pasteur Korea (IP-K) has signed an agreements to continue to mine the chemical compound collection of Novartis Institute for Tropical Diseases (NITD) of Singapore for new drug candidates.

IP-K's PhenomicScreen is a high-throughput, high-content visual screening platform that is ideally suited to identifying lead compounds. Over the past year, PhenomicScreen has been used to search for promising drugs within NITD's chemical compound collection. That deal has now been extended by two years to allow a further exploration of their chemical library.

Dr. Pablo Bifani, Project Team Head at NITD, welcomed his institute's new contract, noting that "The scientific approach we are taking with IP-K is greatly facilitating the selection of candidate compounds for further drug development."

IP-K's Dr. Jonathan Cechetto describes the advantages of PhenomicScreen as being that "The process selects novel targets, and only those which are functionally significant in the disease process". Dr. Priscille Brodin of IP-K adds that "The phenotypic approach does not rely on a predefined target, but rather simultaneously selects both chemical compounds and an unknown cellular target solely by the clearly discernible effect on the disease model".

Center Director of Core Technologies of Institut Pasteur Korea Dr. Veronica Soloveva said that "We are proud to be working with NITD in the fight against infectious diseases". Soloveva is satisfied that the agreement is a vindication of the institute's innovative approach to drug discovery. "Our PhenomicScreen technology is proven to increase the accuracy and speed of drug discovery," she says.


'/>"/>

Contact: Jean Kim
babunn@ip-korea.org
82-318-018-8041
Institut Pasteur Korea
Source:Eurekalert

Page: 1

Related biology news :

1. GenWay Biotech extends the You Test You program overseas
2. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
3. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
4. $5.1 million Army-Md. alliance speeds university research to market
5. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
6. Researchers describe first functioning lipidome of mouse macrophage
7. U of M researcher helps unlock 30 new genes responsible for early onset puberty
8. Stroke research takes 2 steps forward
9. Researchers find link between sugar, diabetes and aggression
10. Arjun Deb awarded Louis N. and Arnold M. Katz Basic Science Research Prize
11. Snakes on a rope: Researchers take a unique look at the climbing abilities of boa constrictors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
Breaking Biology Technology: